Literature DB >> 2495893

Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.

K Ratsula1, J Toivonen, P Lähteenmäki, T Luukkainen.   

Abstract

Levonorgestrel, estradiol and progesterone plasma concentrations were measured over four years of use of a 20 micrograms/day levonorgestrel-releasing intracervical device (LNG-ICD). The mean levonorgestrel concentration showed a slight decline, being 142 + 46 (SD) pg/ml in the third month and 81 +/- 22 pg/ml in the 48th month of LNG-ICD use. However, considerable interindividual variation in levonorgestrel plasma levels between study subjects was observed. In 77% of the monitored cycles, ovulation or a luteinized follicle was observed when judged by a plasma progesterone elevation of over 5 ng/ml. Some follicular function was also noted in anovulatory cycles. Inhibition of ovulatory ovarian function is not the mode of contraceptive action of the LNG-ICD.

Entities:  

Keywords:  Biology; Cervix; Contraception--side effects; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Mode Of Action; Corpus Luteum Hormones; Developed Countries; Endocrine System; Europe; Family Planning; Finland; Genitalia; Genitalia, Female; Hormones; Levonorgestrel; Longitudinal Studies; Northern Europe; Ovulation; Ovulation Suppression; Physiology; Progestational Hormones; Progesterone; Reproduction; Research Methodology; Research Report; Scandinavia; Studies; Urogenital System; Uterus

Mesh:

Substances:

Year:  1989        PMID: 2495893     DOI: 10.1016/s0010-7824(89)80008-3

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Risk of intracranial hypertension with intrauterine levonorgestrel.

Authors:  Mahyar Etminan; Hao Luo; Paul Gustafson
Journal:  Ther Adv Drug Saf       Date:  2015-06

2.  Drug release testing of long-acting intrauterine systems.

Authors:  Quanying Bao; Yuan Zou; Yan Wang; Darby Kozak; Stephanie Choi; Diane J Burgess
Journal:  J Control Release       Date:  2019-11-13       Impact factor: 9.776

3.  Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.

Authors:  Tiina Backman
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Systematic Review of Postfertilization Effects and Potential for Embryo Formation and Loss during the Use of Intrauterine Devices.

Authors:  Cara Buskmiller; Donna Harrison; Lester A Ruppersberger; Patrick P Yeung
Journal:  Linacre Q       Date:  2019-06-27

Review 5.  Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling.

Authors:  Dustin J Costescu
Journal:  Int J Womens Health       Date:  2016-10-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.